Papayotin

Synopsis

Papayotin (Papain, Carica papaya Latex Enzyme)

Identity and Nomenclature

Papayotin is a historical and pharmacognostic synonym for papain, the proteolytic enzyme derived from the latex of Carica papaya L. The term "Papayotin" appears in the pharmacognostic literature as a formal synonym alongside other historical names including "Vegetable pepsin," "Tromasin," and "Arbuz." The term was documented in pharmacological science as early as 1884, when a German-language paper titled Physiologische und therapeutische Wirkungen des Papayotin und Papaïn ("Physiological and therapeutic effects of Papayotin and Papaïn") appeared in Archiv der Pharmazie.

Papain, also known as papaya proteinase I, is a cysteine protease (EC 3.4.22.2) enzyme present in papaya (Carica papaya) and mountain papaya (Vasconcellea cundinamarcensis). Papain is the English translation of 'papaïne', the name given by Wurtz and Bouchut to a proteolytically active constituent in the latex of the tropical papaya fruit (Carica papaya). Chemical databases list "Papayotin" as a recognized synonym alongside entries such as "Papain, Carica papaya," "Papain Water Soluble," "Papainase," and "Papaya Fruit Enzyme."

In historic pharmacopoeial texts, the substance was defined as the inspissated (thickened by evaporation) juice of the unripe fruit of Carica Papaya. It was described as a whitish, slightly astringent powder, soluble in water.

Botanical Source

Carica papaya is a fast-growing, tropical fruit-bearing plant known for its sweet, orange-fleshed fruit and medicinal properties, native to Central America and Mexico, belonging to the family Caricaceae. It is a significant fruit crop cultivated in tropical, sub-tropical, and temperate zones such as Australia, Brazil, China, Hawaii, Malaysia, Nigeria, and India. The plant is cultivated in Sri Lanka, Tanzania, Hawaii, and Florida; it stands 5–6 m in height, bearing fruits of about 30 cm in length and a weight of up to 5 kg.

Common Forms and Preparations

Pharmacognostically, papain (papayotin) is defined as the dried and purified latex of the green fruits and leaves of Carica papaya L., belonging to family Caricaceae. It is a plant-derived cysteine protease (~23.4 kDa) extracted from the latex of the papaya tree. In modern commerce and supplementation it occurs in several distinct forms:

Crude dried latex: The crude dried latex contains a mixture of at least four cysteine proteinases and other enzymes, and early preparations of papain were contaminated by other enzymes; improvements in purification procedures introduced by Kimmel and Smith allowed the isolation of pure papain. It must be noted that the term 'papain' is also applied to the commercial crude dried latex used in industry.
Purified crystalline papain: Papain is commercially provided as a partially purified crystalline form or as crude papain, the latter being a mixture comprising papain, chymopapain, and lysozyme.
Chewable tablets: A widely marketed oral supplement form combining papaya fruit and the enzyme papain, typically taken after meals.
Capsules and powders: When used to aid digestion, papain (papayotin) was historically administered after meals, either in powders, capsules, compressed tablets, or aqueous solution, freshly prepared.
Topical preparations: Papain has also been applied to the skin in a solution and, more recently, incorporated into wound-dressing formulations and ointments.
Papaya extract preparations (e.g., Caricol): Caricol, a papaya extract in supplement form, is available as a packet to be added to water or juice after meals, up to three times daily.

Historical and Traditional Use

Indigenous and Folk Traditions

Both the fruit and various plant parts (leaves, seeds, latex) of Carica papaya are used in traditional medicine systems such as Ayurveda, Unani, and folk medicine for treating digestive issues, infections, inflammation, and skin problems. The entire plant was used as medicine, including the fruit, leaves, roots, peel, bark, seed, and pulp.

In traditional medical cultures, papayas (peel, fruit pulp, seed; rarely leaves and latex) are primarily used to treat asthma, parasitoses, wound healing disorders, and gastro-intestinal problems such as diarrhoea or constipation. Plants are traditionally used to treat several conditions such as stomach disorders, diarrhoea, skin diseases, male contraceptives, and home remedies for colds.

The latex of the papaya plant, containing what was historically called "papayotin," was majorly used in tenderizing meat and, when fermented, becomes an important product in the pharmaceutical industry; the latex is also used in treating fever, stomach aches, beriberi, and as an anthelmintic.

Nineteenth-Century Medical Use of Papayotin

The term "papayotin" was particularly prominent in late nineteenth-century European and American medical literature, where the substance was recognized as a distinct therapeutic agent and prescribed under that name. Professor Schwimmer reported excellent results from the use of papayotin in fissures of the tongue, after chromic acid, iodoform, and nitrate of silver had failed; the papayotin was administered dissolved in distilled water and glycerine and applied with a camel's hair brush from two to six times a day on a previously dried tongue; the mixture stopped pain and appeared to cause a renewal of the epithelium; Schwimmer reported twenty-five cases, some of several years' duration, with complete cure in all except one syphilitic case, in which papayotin nonetheless ameliorated the condition. This 1887 clinical report appeared in the Wiener Medizinische Wochenschrift and was later indexed in the U.S. National Library of Medicine.

The classic pharmacology textbook Pharmacology and Therapeutics treated the substance under the heading "Papain, Papoid, or Papayotin," reflecting the interchangeable use of these terms in nineteenth-century pharmacy and medicine. Papayotin was noted to resemble pepsin in its physiological action, though differing from both pepsin and pancreatin in that it is equally active in neutral, alkaline, or acid media; it converts proteids into soluble peptones and acts as a stimulant to the gastric glands; it also converts starch into maltose, acts upon false membranes more energetically than pepsin, and may dissolve intestinal worms.

The uses of papain (papayotin) were described as more manifold than those of the digestive ferments previously known; like pepsin, it had been successfully employed to dissolve false membrane in diphtheria and croup. Papain was used with some benefit in indurated eczema and syphilitic ulcerations of the tongue; it was highly recommended as a solvent of cerumen, with a solution of 20 grains to 1 ounce of distilled water dropped into the external auditory meatus and syringed an hour later with boric acid solution.

Nineteenth-Century Discovery and Naming

Papain's enzymatic use was first discovered in 1873 by G.C. Roy, who published his results in the Calcutta Medical Journal in an article titled "The Solvent Action of Papaya Juice on Nitrogenous Articles of Food"; in 1879, papain was officially named by Wurtz and Bouchut, who managed to partially purify the product from the sap of papaya. It was not until the mid-twentieth century that complete purification and isolation of papain was achieved. The term "papayotin" appears to have been the name most commonly used in the German-speaking medical world during this same late nineteenth-century period, before "papain" became the universal accepted designation.

Key Constituents and Active Compounds

The Enzyme Complex of Carica papaya Latex

The latex of Carica papaya is a rich source of four cysteine endopeptidases: papain, chymopapain, glycyl endopeptidase, and caricain. The proteins are synthesized as inactive precursors that become active within two minutes of the plant being wounded and the latex expelled; papain is a minor constituent but has been more widely studied because it is more easily purified.

Papain is a cysteine protease extracted from the latex of unripe Carica papaya fruit, renowned for its broad substrate specificity, stability over a wide pH range, and ability to catalyze reactions under mild conditions. Papain (EC 3.4.22.2) belongs to the cysteine protease family, the same family as bromelain, and functions by hydrolyzing peptide bonds in proteins.

Phytochemical Composition of Carica papaya

The use of C. papaya in folk medicine is made possible by the phytochemicals present in the plant, which include tannins, steroids, terpenoids, saponins, phenols, flavonoids, pro-anthocyanidins, alkaloids, anthraquinones, and cardiac glycosides. The pulp contains three essential vitamins—A, C, and E—with potential antioxidant properties, as well as magnesium, potassium, copper, zinc, B-complex vitamins such as pantothenic acid and folate, and dietary fibers.

Papaya has been reported to contain notable concentrations of vitamin C (61.8 mg per 100 g), vitamin A (328 mg per 100 g), riboflavin (0.05 mg per 100 g), folate (38 mg per 100 g), thiamine (0.04 mg per 100 g), niacin (0.34 mg per 100 g), calcium (24 mg per 100 g), iron (0.1 g per 100 g), potassium (257 mg per 100 g), and fiber (0.8 g per 100 g), with a low caloric value of 32 kcal per 100 g.

Mechanism of Action

Protease Activity and Active Site Architecture

Mature papain consists of 212 amino acid residues organized in two domains — an N-terminal α-helix-rich domain and a C-terminal β-sheet-rich domain — with the active site located at the interface between the two domains, containing a catalytic triad of amino acids: cysteine, histidine, and asparagine. The cysteine residue (Cys25) is located in the active site cleft and functions as a nucleophile in the catalytic mechanism; the histidine residue (His159) acts as a general acid-base catalyst, while the asparagine residue (Asn175) stabilizes the histidine residue and helps to orient the substrate.

The His-Cys catalytic diad is in an N/SH protonation state in the noncovalent papain-substrate Michaelis complex; His159 functions as a general base catalyst, abstracting a proton from the Cys25, while the activated thiolate synchronously attacks the substrate's carbonyl group. The catalytic residues of papain — Cys25 and His159 — are evolutionarily preserved in all cysteine proteases.

Substrate Specificity

Papain is a cysteine protease with wide specificity, cleaving the peptide bonds of basic amino acids such as leucine and glycine; it also hydrolyzes esters and amides; and it will digest most protein substrates more extensively than the pancreatic proteases. The papaya fruit, and namely its sap, contains a mixture of proteolytic enzymes such as papain and chymopapain, which specifically hydrolyze polypeptides containing basal amino acids, leucine, and glycine.

pH Stability

A distinguishing characteristic emphasized in the earliest pharmacological descriptions, and confirmed biochemically, is that papain (papayotin) is active across a wide pH range. In this it resembles pepsin, though differing from the latter, as well as from pancreatin, in that it is equally active in neutral, alkaline, or acid media. Papain is a cysteine hydrolase that is stable and active under a wide range of conditions; it is very stable even at elevated temperatures.

Scientific Evidence by Area of Use

1. Digestive Health

Oral bioavailability of intact papain enzyme is negligible, as its activity is luminal — meaning papain acts within the gastrointestinal tract to hydrolyze dietary proteins, not systemically. Papain can be extracted from the latex of the fruit, and it helps break down proteins into smaller peptides and amino acids, making it easier for the digestive system to process and absorb these nutrients.

Papain itself has been used for improving digestion, but there is no reliable evidence that it works for this use in people in the form of convincingly designed and replicated clinical trials. The NIH Office of Dietary Supplements does not maintain a dedicated fact sheet for papain, and NIH resources emphasize that high-quality clinical evidence for many papain indications is limited. Most studies investigating papain for digestive symptoms have been small, of short duration, or conducted in combination with other enzymes, making it difficult to isolate papain's specific contribution.

2. Wound Healing and Enzymatic Debridement

Papain (an enzyme from the latex of Carica papaya) is an interesting natural bioactive macromolecule used as a therapeutic alternative for wound healing due to its debridement action in devitalized or necrotic tissues. Historically, papain-urea ointments were used to remove necrotic (dead) tissue from burns, pressure sores, and ulcers.

A 2017 study found that using dressings containing papain helped lower the amount of dying tissue, reduce the incidence of infection, and lower hospitalization time in people with diabetic foot ulcers. Another 2023 study compared different types of wound dressings for ulcers and also found greater effectiveness in various formulations containing papain extract.

In multiple clinical studies with over 350 people and 30 children, papaya enzyme applied to the skin sped up the healing of skin ulcers or burns. It reduced wound size, removed damaged tissue, accelerated wound closure, and shortened hospital stay. However, the strength of this body of evidence is moderate at best; while a clinical study in patients with large burn wounds found papain-urea debridement effective in removing dead tissue, regulatory policies have since tightened in some countries due to concerns about unapproved topical papain formulations and rare severe reactions, and enzymatic debridement using papain is now typically restricted to specific products and specialist settings, if used at all.

Preclinical data are supportive: a 2017 animal study found that a gel containing 3% papain led to better wound healing in rats than a placebo gel, and a 2019 animal study confirmed these findings. Protease enzymes found in Carica papaya are known to have de-sloughing and wound-healing properties; application to lesions was found to enhance phagocytic cell killing of bacteria; and green papaya is rich in papain and chymopapain, two potent digestive enzymes that can break down dead tissue and have anti-inflammatory properties.

3. Anti-inflammatory Effects

Papain is a proteolytic enzyme derived from Carica papaya L. with potential benefits beyond protein digestion; a 2024 study investigated the potential effects of papain against skin inflammation in house dust mite-exposed NC/Nga atopic dermatitis mice and human HaCaT keratinocytes and their underlying mechanisms. Papain's proteolytic action can reduce the load of damaged proteins and matrix fragments in injured tissue; animal studies suggest that papain may lessen inflammatory markers and protect the gut lining in models of intestinal injury and inflammation, sometimes tested alongside bromelain.

Anti-inflammatory evidence in humans remains sparse. Some studies suggest papain may help reduce inflammation and pain, including post-surgical swelling or joint discomfort; however, more human-based research is needed to confirm these effects. The 2024 atopic dermatitis animal and cell-culture study provides mechanistic plausibility but does not constitute clinical evidence. Overall, the anti-inflammatory evidence base for papain is preliminary and largely preclinical.

4. Herpes Zoster and Viral Conditions

Papain has been studied in combination enzyme preparations for herpes zoster (shingles). A controlled study of 192 patients evaluating enzyme therapy as an alternative treatment for herpes zoster was published in Fortschritte der Medizin in 1995. This study tested a multi-enzyme formulation that included papain; the evidence is thus for a combination product rather than papain alone, limiting conclusions about papain's specific contribution.

5. Oral / Dental Applications

Nineteenth-century clinical reports described the use of papayotin (papain) in fissures of the tongue, where it appeared to stop pain and cause renewal of the epithelium. Papain has wide-ranging commercial applications in the cosmetic industry, including in dental products. Papain is a protease isolated from papaya that mediates the hydrolysis of proteins and is a common ingredient in many products, including toothpaste and contact lens cleaners; however, little research has been done to fully assess its efficacy as an anti-inflammatory in clinical settings.

6. Radiation-Induced Inflammation (Combination Therapy)

A clinical trial protocol registered on ClinicalTrials.gov evaluated Q-Urol, an over-the-counter herbal supplement claiming anti-inflammatory effects and composed of quercetin, pollen extract, bromelain, and papain, for reducing the severity of radiation-induced prostatitis. Because papain is one of several active ingredients in such combination products, study outcomes cannot be attributed to papain alone.

7. Skin Conditions and Cosmetic Applications

Papain, derived from the papaya fruit, is an enzyme that digests intracellular protein bonds; when used topically, papain can improve epidermal exfoliation and may be used in the treatment of hypertrophic scars. The effectiveness of papain, Carica papaya extracts, and other bioactive ingredients in a range of cosmetic formulations, including face masks, scrubs, shampoos, conditioners, and nail care products, has been investigated.

Body Systems and Health Areas Associated with Papayotin/Papain

Gastrointestinal system: Papaya contains the enzyme papain, which increases gut transit time and is also used to ameliorate traumas, allergies, and skin conditions.
Integumentary system (skin and wounds): Because of its protein-breaking ability, papain is being studied for roles beyond digestion, including wound cleaning (debridement) and anti-inflammatory effects.
Immune and inflammatory pathways: Preclinical and limited clinical data suggest involvement in modulating inflammatory cascades, particularly in skin inflammation models.
Musculoskeletal system: For treating pain and swelling (inflammation) following an accident or surgery, a dose of 1500 mg (2520 FIP units) of papain per day has been studied in scientific research.
Oral mucosa: Historical clinical use in tongue fissures, and contemporary commercial use in toothpastes, reflects a recognized association with oral tissue integrity.

Dosage Forms and Dosages Reported in Studies

The following dosages are reported as they appear in source materials; they are not recommendations.

Historical topical dose (papayotin / papain in solution): Papayotin 1 to 2 parts dissolved in distilled water with glycerine (10 parts), applied with a camel's hair brush two to six times daily to previously dried tissue.
Historical oral dose: Dose was recorded as 1–8 grains (approximately 65–520 mg) in nineteenth-century pharmacological references.
Anti-inflammatory / post-surgical use: For treating pain and swelling following an accident or surgery, 1500 mg (2520 FIP units) of papain per day has been studied.
Combination product oral dose: Papain has most often been used by adults in combination with other ingredients at a dose of 1200 mg by mouth daily for up to 10 weeks.
Enteric capsule (autoimmune patent formulation): An enteric capsule formulation has been described comprising an effective amount of papain within a range of about 50 to 100 mg papain per capsule, with a daily dose amount within a range of about 100 to 5000 mg.
Commercial chewable tablet (typical marketed dose): Commercial products in the supplement market typically specify chewing 3 tablets (containing papain plus papaya fruit) following a meal, one to three times daily, though these figures are manufacturer-specified, not clinical trial dosages.

Safety Considerations and Drug Interactions

Allergenicity

Papain is a known occupational allergen — powdered preparations pose an inhalation risk and can cause respiratory sensitization and occupational asthma; allergic cross-reactivity with latex or other plant protease allergens is possible, and individuals with latex allergy should avoid papain-containing products. For allergenicity assessment, the EFSA Panel considered papain as well as three other cysteine endopeptidases known to be present in the food enzyme; papain and chymopapain are known food allergens; homology searches of the amino acid sequences of the four proteins to known allergens identified matches with 6 food and 8 respiratory allergens; the Panel considered that a risk of allergic reactions upon dietary exposure to the food enzyme cannot be excluded.

One case report suggests that people who are allergic to fig and kiwi might also be allergic to papain. A significant concern associated with papain, especially in topical applications, is the potential for allergic reactions; individuals with allergies to latex, papaya, or figs may be more susceptible to allergic responses, ranging from mild skin irritation or blisters to severe systemic reactions like anaphylaxis.

Pregnancy and Lactation

Unripe papaya fruit is possibly unsafe when taken by mouth during pregnancy; there is some evidence that unprocessed papain, one of the chemicals found in unripe papaya fruit, might poison the fetus or cause birth defects. Taking papain by mouth during pregnancy is considered possibly unsafe, with concern that it might cause birth defects or miscarriage; not enough is known about the safety of using papain during breastfeeding.

Drug Interactions

Papain carries a moderate interaction rating with warfarin (Coumadin), which is used to slow blood clotting. Papain might increase the effects of warfarin and increase the chances of bruising and bleeding; regular blood-level monitoring is advised, and the dose of warfarin might need to be changed. This interaction is further noted in clinical trial documentation: caution should be taken when papain is used concurrently with warfarin.

Papain can potentially increase the effects of blood-thinning medications like warfarin, leading to increased risk of bruising and bleeding; individuals with diabetes or those taking medications to lower blood sugar should also use papain with caution, as it might affect blood glucose levels.

Topical Safety and Regulatory Status

Although papain is used therapeutically for wound healing due to its debridement action in necrotic tissues, its use in high doses can induce potential skin irritation and side effects. Very high oral doses have been associated with throat and gastric irritation and, in extreme cases, more serious injury in older reports; overly aggressive or unsupervised topical use, particularly on open wounds or mucous membranes, can lead to ulceration or delayed healing, and for this reason, medical-strength debriding formulations have come under stricter regulation in some regions.

The US Food and Drug Administration has previously issued warnings regarding unapproved topical papain products due to reports of serious adverse events. Specific papain-containing products marketed for disease treatment would be regulated as drugs and require FDA approval; the FDA has issued general warnings about allergenic and safety risks of enzymes when appropriate.

Bleeding Risk and Surgery

There is a concern that papain might increase the risk of bleeding in people with a clotting disorder, and it might also increase the risk of bleeding during surgery; it is advised to stop taking papain 2 weeks before surgery.

EFSA Safety Evaluation

Among the four proteins in the cysteine endopeptidase complex derived from Carica papaya latex, papain and chymopapain are known food allergens; homology searches identified matches with six food and eight respiratory allergens; while the EFSA Panel considered the risk of allergic reactions upon dietary exposure cannot be excluded, it concluded the food enzyme does not give rise to safety concerns under the intended conditions of use; however, the Panel noted the presence of multiple mycotoxins in all food enzyme batches examined, indicating deficiencies in the quality assurance system.

Incompatibilities (Historical Pharmacological Record)

Tannic acid, gallic acid, lead salts, and alcohol are documented antagonists and incompatible substances with papain (papayotin) in the historical pharmacological record.

Summary of Evidence Quality

The body of evidence supporting the use of papayotin/papain varies substantially by application area. Topical wound-debridement applications have the most clinical support, with studies in patients with diabetic foot ulcers and burns, though many studies are small and uncontrolled. Oral digestive use is biologically plausible given the established proteolytic activity in the gut lumen, but rigorous, placebo-controlled human trials isolating papain's effects are lacking. Anti-inflammatory evidence is largely preclinical (animal models and in vitro), with limited and often combination-product human data. Safety signals — particularly regarding allergenicity, latex cross-reactivity, warfarin interaction, and pregnancy risk — are well-documented and based on case reports, pharmacovigilance data, and regulatory review.